REFERENCES
W. E. Powers and L. J. Tolmach. A multi component x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 197:710–711 (1963).
E. J. Hall. The oxygen effect and reoxygenation. In E. J. Hall (ed.), Radiobiology for the Radiobiologist, Lippincott, Philadelphia, 1988, pp. 137–160.
J. E. Moulder and S. Rockwell. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10:695–712 (1984).
L. J. Peters, H. R. Withers, H. D. Thames, and G. H. Fletcher. Tumor radioresistance in clinical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 8:101–108 (1982).
R. A. Gatenby, H. B. Kessler, J. S. Rosenbaum, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:831–838 (1988).
T. Kayama, T. Yoshimoto, S. Fujimoto, and Y. J. Sakurai. Intratumor oxygen pressure in malignant brain tumors. Neurosurgery 74:55–59 (1991).
M. H. Maor, D. H. Hussey, G. H. Fletcher, and R. H. Jesse. Fast neutron therapy for locally advanced head and neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 7:155–159 (1981).
W.-J. Koh, J. S. Rasey, and M. L. Evans. Imaging of hypoxia in human tumors with F-18 fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22:199–212 (1992).
P. E. Valk, C. A. Mathis, M. D. Prados, J. C. Gilbert, and T. F. Budinger. Hypoxia in human gliomas: Demonstration by PET with [F-18] fluoromisonidazole. J. Nucl. Med. 33:2133–2137 (1992).
G. V. Martin, J. H. Caldwell, J. S. Rasey, Z. Grunbaum, M. Cerqueira, and K. A. Krohn. Enhanced binding of the hypoxic cell marker [F-18] fluoromisonidazole in ischemic myocardium. J. Nucl. Med. 30:194–201 (1989).
J. S. Rasey, W. J. Koh, J. R. Grierson, Z. Grunbaum, and K. A. Krohn. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 17:985–991 (1989).
D. R. Hwang, C. S. Dence, T. A. Bonasera, and M. J. Welch. No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues. Int. J. Radiat. Appl. Instrum. A 40:117–126 (1989).
P. A. Jerabeck, T. B. Patrick, M. R. Kilbourn, D. D. Dischino, and M. J. Welch. Synthesis and biodistribution of 18F-labeled fluoronitromidazoles: potential in vivo markers of hypoxic tissue. Appl. Radiat. Isot. 37:599–605 (1986).
J. R. Grierson, J. M. Link, C. A. Mathis, and J. S. Rasey. A radiosynthesis of fluorine-18-fluoromisonidazole. J. Nucl. Med. 30:343–350 (1989).
J. L. Lim and M. Berridge. Efficient radiosynthesis of [18F]fluoromisonidazole suitable for routine PET. J. Label. Compds. Radiopharm. 22:541–543 (1993).
M. Benbouzid, A. Bhati, and R. J. Hamilton. Synthesis of symmetrical diacid triacylglycerols from glycerol-1,3-ditosylate. Fat. Sci. Technol. 90 (8):292–295 (1988).
S. M. Moerlein, J. W. Brodack, B. A. Siegel, and M. J. Welch. Elimination of contaminant kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-deoxy-D-glucose. Appl. Radiat. Isot. 40:741–743 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cherif, A., Yang, D.J., Tansey, W. et al. Rapid Synthesis of 3-[18F]Fluoro-l-(2′-Nitro-1′-Imidazolyl)-2-Propanol ([18F]Fluoromisonidazole). Pharm Res 11, 466–469 (1994). https://doi.org/10.1023/A:1018937709835
Issue Date:
DOI: https://doi.org/10.1023/A:1018937709835